| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Cell-Free DNA Methylation Signature to Detect Metastatic Breast Cancer in Blood
|
Barragan, I.
|
|
|
1 |
S |
p.
|
article
|
| 2 |
A Combined mDETECT Assay for all Subtypes of Breast Cancer and its use in Monitoring Metastatic Disease
|
Frosst, K.
|
|
|
1 |
S |
p.
|
article
|
| 3 |
Analysis of Immunoregulatory Genes Expression in PBMCs as Potential Predictive and Prognostic Biomarkers in NSCLC Patients Treated with Immunotherapy
|
Manuel, A. Moreno
|
|
|
1 |
S |
p.
|
article
|
| 4 |
Analytical Performance of TruSight™ Oncology 500 ctDNA v2: Improved Sensitivity for Small Nucleotide Variants With Reduced DNA Input Requirements
|
Cuadras, M.
|
|
|
1 |
S |
p.
|
article
|
| 5 |
A Narrow NGS Panel in the Analysis of KRAS p.G12C Mutation in Longitudinal Series of NSCLC Patients: A Pilot Study
|
Pepe, F.
|
|
|
1 |
S |
p.
|
article
|
| 6 |
An End-To-End cfRNA-Seq Pipeline for Early Cancer Detection From Liquid Biopsy
|
Belmonte, S.
|
|
|
1 |
S |
p.
|
article
|
| 7 |
A New Platform for the Direct Profiling of Nucleic Acids in Biofluids
|
Detassis, S.
|
|
|
1 |
S |
p.
|
article
|
| 8 |
A Plasma MicroRNA Signature for Early Detection of Paediatric Cerebellar Atrophy Caused By PMM2-CDG
|
Cabus, L.
|
|
|
1 |
S |
p.
|
article
|
| 9 |
Association of IDH1 Mutation Detected in Circulating-free DNA With Survival Outcome in Patients Affected by Glioma
|
Ruglioni, M.
|
|
|
1 |
S |
p.
|
article
|
| 10 |
Author Index
|
|
|
|
1 |
S |
p.
|
article
|
| 11 |
Blood-Based Circulating Tumor Cells and Cell-Free DNA Monitoring for Dynamic Recurrence Risk Prediction in Melanoma
|
Roy, D.
|
|
|
1 |
S |
p.
|
article
|
| 12 |
BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study
|
Elamin, Y.
|
|
|
1 |
S |
p.
|
article
|
| 13 |
CAF-Derived Exosomes as Potential Chromatin Regulators
|
Martínez-Rodríguez, A.
|
|
|
1 |
S |
p.
|
article
|
| 14 |
Cell-Free (cfDNA) Based Evaluation of KRAS Mutation Profile in Solid Tumors With Focus on G12C Variant
|
Limaye, S.
|
|
|
1 |
S |
p.
|
article
|
| 15 |
cfDNA NGS for Identification of Primary and Acquired Resistance in Patients With Lung Cancer and EGFR Mutations
|
Peleg, A.
|
|
|
1 |
S |
p.
|
article
|
| 16 |
Characterization of Plasma Derived Cell Free Nucleic Acid-Based Markers for Disease Monitoring in Acute Myeloid Leukemia
|
Thakral, D.
|
|
|
1 |
S |
p.
|
article
|
| 17 |
Circulating PD-L1 and TIM3 as Prognostic Markers in Patients With Advanced Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor
|
Genova, C.
|
|
|
1 |
S |
p.
|
article
|
| 18 |
Circulating Tumor Cells as a Non-invasive Glioblastoma Diagnostic and Prognostic Tool
|
Lessi, F.
|
|
|
1 |
S |
p.
|
article
|
| 19 |
Circulating Tumor Cells (CTCs), Melatonin, and uNOS: New Frontiers in Cancer Diagnosis and Treatment
|
Tavartkiladze, A.
|
|
|
1 |
S |
p.
|
article
|
| 20 |
Circulating Tumor Cells of Non-small Cell Lung Cancer (NSCLC) Patients. A Potential New Liquid Biopsy Biomarker
|
Armúa, E. Fernández
|
|
|
1 |
S |
p.
|
article
|
| 21 |
Circulating Tumor DNA (ctDNA) Dynamics and Clinical Outcome in Metastatic Colorectal Cancer (mCRC) Patients (pts) Undergoing Front-line Chemotherapy
|
Ghidini, M.
|
|
|
1 |
S |
p.
|
article
|
| 22 |
Circulating Tumor DNA Monitoring in Advanced Mutated Melanoma Treated With Immune Checkpoint Inhibitors: A Pilot Study
|
Monica, G.
|
|
|
1 |
S |
p.
|
article
|
| 23 |
Clinical and Molecular Utility of Cell Block From Pleural Exudate Concerning Cytology and Surgical Biopsy
|
Fernández, C.
|
|
|
1 |
S |
p.
|
article
|
| 24 |
Clinical Feasibility of NGS Liquid Biopsy Analysis in NSCLC Patients Using Oncomine Precision Assay with Genexus™ Integrated Sequencer
|
Buglioni, S.
|
|
|
1 |
S |
p.
|
article
|
| 25 |
Clinical Utility of Combined Plasma and Tissue NGS in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer
|
De Cabo, H. Bote
|
|
|
1 |
S |
p.
|
article
|
| 26 |
Clinical Utility of Liquid Biopsy in the Diagnosis and Monitoring of Patients Affected by PROS Syndromes
|
Munera-Maravilla, E.
|
|
|
1 |
S |
p.
|
article
|
| 27 |
Comparison of Tumor-associated miRNAs in EpCAM+, CD47+ and CD29+ Extracellular Vesicles (EVs) Immunomagnetically Enriched From Cancer Patients’ Plasma
|
Bregola, G.
|
|
|
1 |
S |
p.
|
article
|
| 28 |
Comprehensive Analysis of Preanalytical Parameters in cfDNA from Lung, Colon, and Breast Cancer Patients
|
Denninghoff, V.
|
|
|
1 |
S |
p.
|
article
|
| 29 |
Computational Profiling of Aberrant DNA Methylation in Cancer: a Promising Source of Biomarkers for Liquid Biopsies
|
Ibrahim, J.
|
|
|
1 |
S |
p.
|
article
|
| 30 |
Contents
|
|
|
|
1 |
S |
p.
|
article
|
| 31 |
Detection of Activating Mutations in Liquid Biopsy of Egyptian Solid Tumor Patients Using Targeted Next Generation Sequencing: A Pilot Study
|
Kassem, N.
|
|
|
1 |
S |
p.
|
article
|
| 32 |
Detection of Circulating Tumor Cells in Peripheral Blood of Pediatric Osteosarcoma Patients
|
Morelli, M.
|
|
|
1 |
S |
p.
|
article
|
| 33 |
Detection of Somatic Alterations in Peritoneal Lavages of Early-Stage Endometrial Carcinoma Patients
|
Ibañez, M. Garzón
|
|
|
1 |
S |
p.
|
article
|
| 34 |
Development of a Horizontal Data Integration Classifier for Non-invasive Early Diagnosis of Breast Cancer: Preliminary Results From the RENOVATE Trial
|
Dameri, M.
|
|
|
1 |
S |
p.
|
article
|
| 35 |
Development of Automated cfDNA Extraction From Various Plasma Volumes and Implications on Sensitivity and Reproducibility of qPCR and dPCR Analysis
|
Hampshire, T.
|
|
|
1 |
S |
p.
|
article
|
| 36 |
Direct Saliva Analysis by MALDI Mass Spectrometry: A Workflow Suitable for Future Clinical Applications
|
Sellami, L.
|
|
|
1 |
S |
p.
|
article
|
| 37 |
Early Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization
|
Diaz, A. Garcia
|
|
|
1 |
S |
p.
|
article
|
| 38 |
Enhanced Blood Sampling for Ultra-sensitive Detection of ctDNA and CTCs in Neoadjuvant-treated Early Breast Cancer Patients
|
Alba-Bernal, A.
|
|
|
1 |
S |
p.
|
article
|
| 39 |
EPIC Array Study in Liquid Biopsy Identifies a Non-invasive Epigenetic Signature for Early Diagnosis in Non-small Cell Lung Cancer
|
Sandoval, J.
|
|
|
1 |
S |
p.
|
article
|
| 40 |
Evaluation of Circulating Tumour DNA During the Clinical Follow-up of Melanoma Patients
|
Rizo-Potau, D.
|
|
|
1 |
S |
p.
|
article
|
| 41 |
Evaluation of Parsortix PR1 and PX+ Systems for the Isolation of Circulating Tumour Cells in Patients With Resectable Lung Cancer
|
Saini, V.M.
|
|
|
1 |
S |
p.
|
article
|
| 42 |
Exploring the Role of CK+/CD45+ (Dual-Positive) Circulating Cells in Patients With Early Breast Cancer (EBC)
|
Nicolo, E.
|
|
|
1 |
S |
p.
|
article
|
| 43 |
Extracellular Vesicles As Mediators of Resistance to EGFR-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Preclinical Models
|
Pérez-Capó, M.
|
|
|
1 |
S |
p.
|
article
|
| 44 |
Extracellular Vesicles Carry SARS-COV-2 Proteins Associated With Lower Antibody Production, Cardiovascular Complications, and Worse Outcomes in Patients With Severe COVID-19
|
de Miguel Perez, D.
|
|
|
1 |
S |
p.
|
article
|
| 45 |
Following Therapy Response Through Liquid Biopsies in Metastatic Colorectal Cancer – The Patient’s Experience
|
Janssens, K.
|
|
|
1 |
S |
p.
|
article
|
| 46 |
Fully Automated Cell-Free DNA Extraction From Up to 8 ml Plasma Enables Sensitive Mutation Detection With Digital PCR and NGS
|
Hampshire, T.
|
|
|
1 |
S |
p.
|
article
|
| 47 |
Gene Expression Signatures in Conjunctival Fornix Aspirates of Patients With Dry Eye Disease Associated with Meibomian Gland Dysfunction
|
Giménez, A.
|
|
|
1 |
S |
p.
|
article
|
| 48 |
Genomic Profiling in NSCLC: Insights from Liquid Biopsy
|
Ercolani, C.
|
|
|
1 |
S |
p.
|
article
|
| 49 |
Glioma Patient Management: Utilizing MGMT Methylation in Extracellular Vesicle-Based Liquid Biopsy
|
De Caceres, I. Ibanez
|
|
|
1 |
S |
p.
|
article
|
| 50 |
Heterochromatin Profiling in Lymphoma Patient Plasma for the Discovery of Novel Chromatin Variants
|
De Michino, S.
|
|
|
1 |
S |
p.
|
article
|
| 51 |
Heterogeneity of Somatostatin Receptors on Circulating Tumor Cells in Neuroendocrine Tumors and Melatonin's Potential in Non-Small-Cell Lung Cancer
|
Tavartkiladze, A.
|
|
|
1 |
S |
p.
|
article
|
| 52 |
High Level of Circulating Tumour DNA at Diagnosis Correlates With Disease Spreading and Defines Multiple Myeloma Patients With Poor Prognosis
|
Martello, M.
|
|
|
1 |
S |
p.
|
article
|
| 53 |
Highly Sensitive Detection of ctDNA in Early Breast Cancer using Plasma-SeqSensei™ and Droplet Digital PCR with Increased Blood Volumes
|
Sanchez-Martin, Victoria
|
|
|
1 |
S |
p.
|
article
|
| 54 |
High Sensitivity Detection of Specific Ultra Low-Frequency Somatic Mutations for Minimal Residual Disease (MRD) Monitoring
|
Han, T.
|
|
|
1 |
S |
p.
|
article
|
| 55 |
High-Throughput Secretome Profiling of Early Breast Cancer
|
Lombardo, I.
|
|
|
1 |
S |
p.
|
article
|
| 56 |
Impact of cfDNA Input on Enzymatic Methylation Conversion and Library Preparation Robustness
|
Kunej, U.
|
|
|
1 |
S |
p.
|
article
|
| 57 |
Impact of Liquid Biopsy Preanalytics on cfDNA Fragmentation Analyses
|
Hallermayr, A.
|
|
|
1 |
S |
p.
|
article
|
| 58 |
Impact of PROphet Assay in Changing Physician’s Therapeutic Decision-Making for Checkpoint Immunotherapy in NSCLC (Non-Small Cell Lung Cancer)
|
Gandara, D.
|
|
|
1 |
S |
p.
|
article
|
| 59 |
Impact of Reference Materials for Analytical Performance Evaluation of Liquid Biopsy NGS Assays
|
Hallermayr, A.
|
|
|
1 |
S |
p.
|
article
|
| 60 |
IMPRESS: Improved Multiplex Methylation Profiling Using Restriction Enzymes and smMIP Sequencing for Highly Sensitive Multi-Cancer Detection
|
Neefs, I.
|
|
|
1 |
S |
p.
|
article
|
| 61 |
Integrating Idylla TM Alongside Real-time PCR and NGS for Investigation of Gene Fusions in Pleural Effusions of Lung Adenocarcinoma
|
Lopez, G.
|
|
|
1 |
S |
p.
|
article
|
| 62 |
KRAS Mutations, Potential Biomarkers for the Identification of Non-small-Cell Lung Cancer Patients That May Benefit From Immunotherapy-Based Treatments
|
Robado De Lope, L.
|
|
|
1 |
S |
p.
|
article
|
| 63 |
Liquid Biopsies: Uncovering Insights That Drive Development and Commercialization in the Clinic
|
Jones, J.
|
|
|
1 |
S |
p.
|
article
|
| 64 |
Liquid Biopsy Analysis Shows MAGI2 Gene as Potential Negative Prognosis Biomarker in NSCLC Patients
|
Mediavilla, P.
|
|
|
1 |
S |
p.
|
article
|
| 65 |
Liquid Biopsy-based Risk Stratification and Intensification of Treatment In EGFR Mutant Advanced NSCLC (L-BRITE)U
|
Baskarane, H.
|
|
|
1 |
S |
p.
|
article
|
| 66 |
Liquid Biopsy Characterization of CTCs and THCs Isolated in Patients with UC
|
Rubio, C.
|
|
|
1 |
S |
p.
|
article
|
| 67 |
Liquid Biopsy Monitoring in BRAF-V600E Mutated NSCLC Patients Treated With Dabrafenib Plus Trametinib: A Prospective, Explorative, Multicentric Study. LiBRA_study (GOIRC-03-2020)
|
Pluchino, M.
|
|
|
1 |
S |
p.
|
article
|
| 68 |
Longitudinal Plasma ctDNA Testing in Resected Early-Stage NSCLC
|
Feng, J.
|
|
|
1 |
S |
p.
|
article
|
| 69 |
Longitudinal Tracking of ALK-positive Lung Cancer From Plasma Using Circulating-Tumor RNA and Circulating-Tumor DNA in the BRIGHTSTAR Clinical Trial
|
Heeke, S.
|
|
|
1 |
S |
p.
|
article
|
| 70 |
Molecular Intelligence Targeting Driver Activating Mutations in Correlation With Gut Microbiome in Egyptian Colorectal Cancer
|
Kassem, N.
|
|
|
1 |
S |
p.
|
article
|
| 71 |
Moving Towards Global Harmonization of Liquid Biopsy Frameworks and Standards: The BLOODPAC Experience
|
Leiman, L.
|
|
|
1 |
S |
p.
|
article
|
| 72 |
Multilayer Characterization of Plasma EV Concentration and Cargo Allows to Diagnose and Monitor Glioblastoma by Liquid Biopsy
|
Zaccheroni, E.
|
|
|
1 |
S |
p.
|
article
|
| 73 |
Mutational Prognosis of Survival by Liquid Biopsy in Advanced EGFRm NSCLC
|
Galvez-Nino, M.
|
|
|
1 |
S |
p.
|
article
|
| 74 |
Nanoscopic Cancer Biomarkers Characterization of Extracellular Vesicles in Liquid Biopsy
|
Triki, M.
|
|
|
1 |
S |
p.
|
article
|
| 75 |
Negative Predictive Value of Pre-diagnostic Plasma ctDNA Testing in Patients With Suspected Lung Cancer
|
García-Pardo, M.
|
|
|
1 |
S |
p.
|
article
|
| 76 |
Network Analysis Identifies Circulating miR-155 as Predictive Biomarker of Type 2 Diabetes Mellitus Development in Obese Patients: A Pilot Study
|
Catanzaro, G.
|
|
|
1 |
S |
p.
|
article
|
| 77 |
Next-Generation Sequencing Analysis of Extracellular Vesicle microRNAs for Breast Cancer Staging
|
Martínez, C. González
|
|
|
1 |
S |
p.
|
article
|
| 78 |
Next Generation Sequencing in Liquid Biopsies: Towards Personalized Cancer Treatment.
|
Garcia, S. Gallach
|
|
|
1 |
S |
p.
|
article
|
| 79 |
NGS Testing on Plasma-based ctDNA Samples at Key Clinical Timepoints in Advanced NSCLC: Handling of Blood Samples and Real-World Experience
|
Verzè, M.
|
|
|
1 |
S |
p.
|
article
|
| 80 |
Non-invasive Assessment of Pathological Complete Response and Minimal Residual Disease Through Plasma Methylomics in Patients With Triple Positive Breast Cancer
|
Ravera, F.
|
|
|
1 |
S |
p.
|
article
|
| 81 |
Novel and Non-invasive Tool for Immunotherapy-Response Prediction in Non-muscle-Invasive Bladder Cancer Patients Based on miRNAs and Cytokine Detection in Urine
|
De Bernardo, Á. Martín
|
|
|
1 |
S |
p.
|
article
|
| 82 |
Optimization of CTCs and THCs Isolation From Human Blood Based on Genesis Technology as a Strategy of Urothelial Carcinoma Monitoring
|
Arévalo, I.
|
|
|
1 |
S |
p.
|
article
|
| 83 |
Ovarian Cancer Is Detectable From Peripheral Blood Using Machine Learning Over T Cell Repertoires
|
Efroni, S.
|
|
|
1 |
S |
p.
|
article
|
| 84 |
PD-L1 and BRAFV600E Expression on CTCs from Early-stage Colorectal Cancer Patients
|
Aznar-Peralta, I.
|
|
|
1 |
S |
p.
|
article
|
| 85 |
Performance of Circulating Tumor DNA (ctDNA) Genomic and Epigenomic Profiling (GuardantINFINITY) in the TRESR and ATTACC Studies
|
Silverman, I.
|
|
|
1 |
S |
p.
|
article
|
| 86 |
PIK3CA testing in HR+/HER2− Metastatic Breast Cancer: Real-world data from referral molecular pathology labs
|
Venetis, K.
|
|
|
1 |
S |
p.
|
article
|
| 87 |
Prognostic and Predictive Non-Invasive Biomarkers in Cutaneous Melanoma Treated With Anti PD-1 Antibodies
|
Torres-Martínez, S.
|
|
|
1 |
S |
p.
|
article
|
| 88 |
Prognostic Potential of Candidate miRNAs in Lung Cancer: Insights from Tissue and Liquid Biopsies
|
Garcia, A.
|
|
|
1 |
S |
p.
|
article
|
| 89 |
Prognostic Significance of Circulating Tumour Cells and Disseminating Circulating Tumour Cell Clusters in Epithelial Ovarian Cancer
|
Ward, M.
|
|
|
1 |
S |
p.
|
article
|
| 90 |
Prospective On-Treatment Dynamics of Circulating Extracellular Vesicles in the First-Line Setting of Patients With Advanced Non-small Cell Lung Cancer
|
Gristina, V.
|
|
|
1 |
S |
p.
|
article
|
| 91 |
Pulmonary MicroRNA Profiling in a Rat Model of Ventilator-Induced Lung Injury
|
Helguera, G. Sánchez
|
|
|
1 |
S |
p.
|
article
|
| 92 |
Refinement of MRD Assessment in Hairy Cell Leukemia by Integrated Molecular and Flow Cytometry Analysis
|
Urbani, G.
|
|
|
1 |
S |
p.
|
article
|
| 93 |
See.d®, a Novel Automated Platform To Standardize Blood Sample Processing for Cells on SBS® Slides and Plasma for Liquid Biopsy
|
Stepien, G.
|
|
|
1 |
S |
p.
|
article
|
| 94 |
Simulating Cell-Free Chromatin Using Breast and Colorectal Cancer Preclinical Models for Cancer-Specific Biomarker Discovery
|
Main, S.
|
|
|
1 |
S |
p.
|
article
|
| 95 |
Somatic Mutation Calling from cfDNA Using Machine Learning
|
Akbarinejad, S.
|
|
|
1 |
S |
p.
|
article
|
| 96 |
TCR-β Repertoire as a Source of Biomarkers for anti-PD1 Treatment Alone or in Combination With Chemotherapy in Advanced-stage NSCLC Patients
|
Manuel, A. Moreno
|
|
|
1 |
S |
p.
|
article
|
| 97 |
Technical Advancements in cfMeDIP-Seq Library Preparation
|
Dameri, M.
|
|
|
1 |
S |
p.
|
article
|
| 98 |
Technological Platform Development for Early Cancer Detection, Towards a Focused Multi-Cancer Detection
|
Vaquer, C.
|
|
|
1 |
S |
p.
|
article
|
| 99 |
TGF-β mRNA Expression Levels in Extracellular Vesicles Are Associated With Immunotherapy Response in Metastatic Melanoma Patients
|
Crucitta, S.
|
|
|
1 |
S |
p.
|
article
|
| 100 |
The Direct Interaction Between Lung Cancer Cells and Platelets Promotes Resistance to Chemotherapy
|
Cerón-Hernández, J.
|
|
|
1 |
S |
p.
|
article
|
| 101 |
The Prognostic Value of the Circulating-Tumor DNA in High-Grade Serous Epithelial Ovarian Cancer: Experience From MITO-16a/MANGO-OV2a/ Clinical Trial
|
Paracchini, L.
|
|
|
1 |
S |
p.
|
article
|
| 102 |
Total RNA-Sequencing From Plasma Cell-Free RNA To Identify Predictive/Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients
|
Gurioli, G.
|
|
|
1 |
S |
p.
|
article
|
| 103 |
Use of Circulating Extracellular Vesicles and CtDNA From Lymphatic Fluid Exudate as Markers for Minimal Residual Disease in Melanoma Patients
|
Baston, Enrique
|
|
|
1 |
S |
p.
|
article
|
| 104 |
Utility of Liquid Biopsy for Comprehensive Genomic Profiling in a First Diagnostic Context: A Comparative Analysis with Tissue Biopsy
|
Freire, J.
|
|
|
1 |
S |
p.
|
article
|
| 105 |
Utility of Liquid Biopsy for Molecular Profiling and Monitoring in Metastatic Colorectal Cancer: A Pilot Study in a Real-World Cohort
|
Caramelo, B.
|
|
|
1 |
S |
p.
|
article
|
| 106 |
Utility of Ultra-Low-Pass Whole Genome Sequencing in Bile CfDNA for the Management of Patients With Biliary Strictures
|
Arechederra, M.
|
|
|
1 |
S |
p.
|
article
|
| 107 |
YES1 as a Possible Liquid Biopsy Biomarker in Lung Cancer
|
Otegui, N.
|
|
|
1 |
S |
p.
|
article
|
Journal description